BOB Capital Markets Ltd.
Q3 revenue up 6% QoQ to Rs 5.4bn supported by sequential recovery in API business to parent and PLI benefits
Alivus Life Sciences has gained 20.70% in the last 6 Months
More from Alivus Life Sciences Ltd.
Recommended